SCHEMBL1628860

SCHEMBL1628860

CN(C1CCCCC1)S(=O)(=O)c1cc(-c2ccnn2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 5/20 0.45
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
GAA P10253 2/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 2/20 0.38
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 2/20 0.36
MCOLN3 Q8TDD5 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NR3C2 P08235 1/20 0.36
LMNA P02545 3/20 0.35
TP53 P04637 1/20 0.34
PTAFR P25105 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629715 0.85 HSP90AA1 (0.52) HSP90AA1GAAALDH1A1MEN1KMT2A
SCHEMBL1628849 0.85 MEN1 (0.45) HSP90AA1HTR2AHTR2CGAAALDH1A1
SCHEMBL1629180 0.83 HSP90AA1 (0.59) HSP90AA1PKMNR3C2
SCHEMBL1629206 0.82 HSP90AA1 (0.51) HSP90AA1TSHRNR3C2TP53
SCHEMBL1629701 0.81 HSP90AA1 (0.52) HSP90AA1GAAALDH1A1KMT2ATSHR
SCHEMBL1629130 0.80 HSP90AA1 (0.49) HSP90AA1GAAALDH1A1NR3C2TP53
SCHEMBL1629115 0.80 HSP90AA1 (0.51) HSP90AA1NR3C2
SCHEMBL4941503 0.80 HSP90AA1 (0.51) HSP90AA1HTR2AHTR2CGAAALDH1A1
SCHEMBL1630408 0.79 HSP90AA1 (0.50) HSP90AA1GAAALDH1A1KDM4EPKM
SCHEMBL1629903 0.79 HSP90AA1 (0.50) HSP90AA1ALDH1A1HPGDTSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885HTR2A 2378/4885HTR2C 2069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.